Evolus Price To Sales Ratio from 2010 to 2024
| EOLS Stock | USD 11.33 0.26 2.24% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 2.96585166 | Current Value 4.6 | Quarterly Volatility 3.31214055 |
Check Evolus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.2 M, Interest Expense of 14.5 M or Selling General Administrative of 81.7 M, as well as many indicators such as Price To Sales Ratio of 4.6, Dividend Yield of 0.0 or Days Sales Outstanding of 74.33. Evolus financial statements analysis is a perfect complement when working with Evolus Valuation or Volatility modules.
Evolus | Price To Sales Ratio |
Latest Evolus' Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Evolus Inc over the last few years. Price to Sales Ratio is figured by comparing Evolus Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Evolus sales, a figure that is much harder to manipulate than other Evolus Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. Evolus' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolus' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 3.68 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Evolus Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 7.60 | |
| Geometric Mean | 6.64 | |
| Coefficient Of Variation | 43.56 | |
| Mean Deviation | 2.98 | |
| Median | 9.84 | |
| Standard Deviation | 3.31 | |
| Sample Variance | 10.97 | |
| Range | 7.8348 | |
| R-Value | (0.79) | |
| Mean Square Error | 4.53 | |
| R-Squared | 0.62 | |
| Significance | 0.0005 | |
| Slope | (0.58) | |
| Total Sum of Squares | 153.58 |
Evolus Price To Sales Ratio History
About Evolus Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Evolus income statement, its balance sheet, and the statement of cash flows. Evolus investors use historical funamental indicators, such as Evolus's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Evolus investors may use each financial statement separately, they are all related. The changes in Evolus's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evolus's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Evolus Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Evolus. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 2.97 | 4.60 |
Pair Trading with Evolus
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evolus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will appreciate offsetting losses from the drop in the long position's value.Moving together with Evolus Stock
Moving against Evolus Stock
| 0.63 | SLS | Sellas Life Sciences | PairCorr |
| 0.57 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.46 | DSGN | Design Therapeutics | PairCorr |
| 0.44 | DYAI | Dyadic International | PairCorr |
| 0.39 | HCM | HUTCHMED DRC | PairCorr |
The ability to find closely correlated positions to Evolus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evolus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evolus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evolus Inc to buy it.
The correlation of Evolus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evolus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evolus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evolus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Evolus Stock Analysis
When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.